logo biblio digital exactas
logo twitter logo instagram logo whatsapp logo mail

Navegar

Colección

Datos Estadísticas

Lista de

Melanoma, Experimental
11
"Selective hemangioma cell dysfunction and apoptosis triggered by in vitro treatment with imiquimod" (2018) Rocco, R.;Alegre, N.;Pozner, R. (...)Gazzaniga, S. Toxicology Letters. 288:82-88
"Human MageB2 protein expression enhances E2F transcriptional activity, cell proliferation, and resistance to ribotoxic stress" (2015) Peche, L.Y.;Ladelfa, M.F.;Toledo, M.F. (...)Monte, M. Journal of Biological Chemistry. 290(49):29652-29662
"Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β" (2015) Alamino, V.A.;Mascanfroni, I.D.;Montesinos, M.M. (...)Pellizas, C.G. Cancer Research. 75(7):1265-1274
"Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β" (2015) Alamino, V.A.;Mascanfroni, I.D.;Montesinos, M.M. (...)Pellizas, C.G. Cancer Research. 75(7):1265-1274
"Antitumor activity of histamine and clozapine in a mouse experimental model of human melanoma" (2013) Massari, N.A.;Medina, V.A.;Cricco, G.P. (...)Rivera, E.S. Journal of Dermatological Science. 72(3):252-262
"Induction and Rejoining of DNA Double Strand Breaks Assessed by H2AX Phosphorylation in Melanoma Cells Irradiated with Proton and Lithium Beams" (2009) Ibañez, I.L.;Bracalente, C.;Molinari, B.L. (...)Durán, H. International Journal of Radiation Oncology Biology Physics. 74(4):1226-1235
"Targeting tumor-associated macrophages and inhibition of MCP-1 reduce angiogenesis and tumor growth in a human melanoma xenograft" (2007) Gazzaniga, S.;Bravo, A.I.;Guglielmotti, A. (...)Wainstok, R. Journal of Investigative Dermatology. 127(8):2031-2041
"Suppression of SPARC expression by antisense RNA abrogates the tumorigenicity of human melanoma cells" (1997) Fernanda Ledda, M.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Nature Medicine. 3(2):171-176
"Tumor cells engineered to express interleukin-6 exhibit a reduced tumorigenicity depending on the tumor cell model." (1996) Ledda, M.F.;Adris, S.;Bravo, A.I. (...)Podhajcer, O.L. Cellular and molecular biology (Noisy-le-Grand, France). 42(5):769-778